Largest pharmaceutical companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 52 pharmaceutical companies ranked by revenue, at TRY 4.75T, ahead of Eli Lilly (TRY 3.29T) and Merck & Co (TRY 3.28T). Figures as of 18 Nov 2026, 22:22 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 52
- First
- Johnson & JohnsonTRY 4.75T
- Median
- TRY 161.5B
- Combined market value
- TRY 255.18T
- Countries
- 10
- Not ranked
- 9no revenue on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | TRY 4.75T | TRY 33.11T | TRY 13,754.93 | 2.15% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | TRY 3.29T | TRY 62.13T | TRY 69,745.63 | 2.32% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | TRY 3.28T | TRY 17.13T | TRY 6,949.60 | 3.90% down | 51% up | ||
| 4 | PfizerPFE · Health Care | TRY 3.16T | TRY 8.07T | TRY 1,415.34 | 1.44% down | 14% up | ||
| 5 | AbbVieABBV · Health Care | TRY 3.08T | TRY 25.5T | TRY 14,426.29 | 2.33% down | 26% up | ||
| 6 | AstraZenecaAZN · Health Care | TRY 2.96T | TRY 13.98T | TRY 9,016.62 | 1.93% down | 2% up | ||
| 7 | NovartisNVS · Health Care | TRY 2.75T | TRY 14.79T | TRY 7,828.76 | 2.46% down | 25% up | ||
| 8 | SanofiSNY · Health Care | TRY 2.44T | TRY 5.71T | TRY 2,376.72 | 0.86% down | 4% down | ||
| 9 | Bristol-Myers SquibbBMY · Health Care | TRY 2.43T | TRY 6.14T | TRY 3,004.19 | 2.92% down | 34% up | ||
| 10 | Novo NordiskNVO · Health Care | TRY 2.31T | TRY 8.77T | TRY 1,988.84 | 3.12% down | 17% down | ||
| 11 | Abbott LaboratoriesABT · Health Care | TRY 2.24T | TRY 9.13T | TRY 5,269.95 | 0.22% down | 17% down | ||
| 12 | GSKGSK · Health Care | TRY 2.19T | TRY 4.91T | TRY 2,450.37 | 1.34% down | 6% up | ||
| 13 | Takeda PharmaceuticalTAK · Health Care | TRY 1.42T | TRY 3.43T | TRY 1,072.85 | 1.71% down | 54% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | TRY 870.5B | TRY 2.49T | TRY 2,130.07 | 0.92% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | TRY 723.5B | TRY 4.93T | TRY 47,692.34 | 1.28% down | 36% up | ||
| 16 | ViatrisVTRS · Health Care | TRY 721.3B | TRY 1.17T | TRY 1,022.92 | 0.83% down | 96% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | TRY 605.3B | TRY 6.86T | TRY 27,058.43 | 0.42% up | 27% up | ||
| 18 | ZoetisZTS · Health Care | TRY 477.5B | TRY 1.75T | TRY 4,316.13 | 2.50% up | 29% down | ||
| 19 | GrifolsGRFS · Health Care | TRY 421.1B | TRY 290.8B | TRY 427.23 | 1.85% down | 1% up | ||
| 20 | BeOne MedicinesONC · Health Care | TRY 269.5B | TRY 2.33T | TRY 20,357.50 | 2.34% down | 17% up | ||
| 21 | Elanco Animal HealthELAN · Health Care | TRY 237.8B | TRY 673.1B | TRY 1,346.74 | 3.29% up | 20% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | TRY 215.3B | TRY 802.2B | TRY 12,497.47 | 2.93% up | 37% up | ||
| 23 | GenmabGMAB · Health Care | TRY 187.6B | TRY 1.59T | TRY 2,570.92 | 1.91% down | 70% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | TRY 187.3B | TRY 1.01T | TRY 7,535.71 | 4.54% down | 66% down | ||
| 25 | Dr. Reddy's LaboratoriesRDY · Health Care | TRY 180.3B | TRY 629.9B | TRY 755.59 | 1.28% up | 5% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | TRY 162.5B | TRY 600.2B | TRY 3,098.52 | 4.99% up | 11% up | ||
| 27 | United TherapeuticsUTHR · Health Care | TRY 160.5B | TRY 1.24T | TRY 29,120.91 | 1.16% down | 23% up | ||
| 28 | Amneal PharmaceuticalsAMRX · Health Care | TRY 152.3B | TRY 384.5B | TRY 1,103.62 | 3.60% up | 83% up | ||
| 29 | Royalty PharmaRPRX · Health Care | TRY 120B | TRY 1.99T | TRY 3,463.70 | 0.01% down | 78% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | TRY 87.3B | TRY 253.8B | TRY 3,037.99 | 0.22% down | 20% down | ||
| 31 | AlkermesALKS · Health Care | TRY 74.4B | TRY 397.1B | TRY 2,363.10 | 3.08% up | 58% up | ||
| 32 | Legend BiotechLEGN · Health Care | TRY 51.9B | TRY 159B | TRY 819.65 | 0.87% up | 42% down | ||
| 33 | Madrigal PharmaceuticalsMDGL · Health Care | TRY 48.3B | TRY 466.4B | TRY 20,079.08 | 5.67% down | 24% down | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | TRY 47.6B | TRY 230.1B | TRY 1,381.55 | 1.59% up | 64% down | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | TRY 41.8B | TRY 307.4B | TRY 2,174.46 | 0.28% up | 10% up | ||
| 36 | Ascendis PharmaASND · Health Care | TRY 40.3B | TRY 894.4B | TRY 13,635.39 | 0.32% down | 28% up | ||
| 37 | Corcept TherapeuticsCORT · Health Care | TRY 38.4B | TRY 374.2B | TRY 3,419.31 | 3.25% down | 8% down | ||
| 38 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | TRY 34.2B | TRY 376.7B | TRY 4,794.30 | 0.06% down | 126% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | TRY 32.2B | TRY 355.5B | TRY 6,758.93 | 1.43% down | 7% down | ||
| 40 | TG TherapeuticsTGTX · Health Care | TRY 31.1B | TRY 504.1B | TRY 3,335.08 | 5.44% up | 107% up | ||
| 41 | InsmedINSM · Health Care | TRY 30.6B | TRY 1.33T | TRY 6,042.69 | 1.69% down | 40% down | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | TRY 26.3B | TRY 304.6B | TRY 4,665.18 | 0.59% up | 31% up | ||
| 43 | BridgeBio PharmaBBIO · Health Care | TRY 25.3B | TRY 766.5B | TRY 3,934.81 | 1.58% up | 17% up | ||
| 44 | Travere TherapeuticsTVTX · Health Care | TRY 24.8B | TRY 243.3B | TRY 2,534.10 | 1.68% down | 44% up | ||
| 45 | Ligand PharmaceuticalsLGND · Health Care | TRY 13.5B | TRY 301.4B | TRY 15,066.87 | 1.67% up | 43% up | ||
| 46 | Rhythm PharmaceuticalsRYTM · Health Care | TRY 9.6B | TRY 416.3B | TRY 6,004.35 | 2.08% up | 13% up | ||
| 47 | CytokineticsCYTK · Health Care | TRY 4.4B | TRY 360.6B | TRY 2,588.57 | 0.64% down | 20% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | TRY 2.3B | TRY 418.6B | TRY 6,413.92 | 2.00% up | 46% up | ||
| 49 | Roivant SciencesROIV · Health Care | TRY 416.6M | TRY 1.42T | TRY 1,953.53 | 0.05% up | 90% up | ||
| 50 | Dianthus TherapeuticsDNTH · Health Care | TRY 102.7M | TRY 238.5B | TRY 4,235.93 | 3.45% down | 113% up | ||
| 51 | Spyre TherapeuticsSYRE · Health Care | TRY 0 | TRY 486B | TRY 5,117.62 | 8.15% up | 286% up | ||
| 52 | Praxis Precision MedicinesPRAX · Health Care | TRY 0 | TRY 430.3B | TRY 15,393.72 | 0.04% up | 61% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4398 TRY). 9 companies have no revenue on file and are not ranked here.
Questions and answers
Which pharmaceutical companies rank first by revenue?
Johnson & Johnson (TRY 4.75T), Eli Lilly (TRY 3.29T) and Merck & Co (TRY 3.28T) are the top three of the 52 pharmaceutical companies ranked by revenue as of 18 Nov 2026, 22:22 UTC.
How many pharmaceutical companies are in this ranking?
52 are ranked by revenue. 9 more have no revenue on file and are left out rather than ranked at zero.
What are these pharmaceutical companies worth together?
The 52 pharmaceutical companies ranked by revenue have a combined market value of TRY 255.18T as of 18 Nov 2026, 22:22 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies by revenue”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.